
GC38755
CKI-7
Also known as N-(2-aminoethyl)-5-chloroisoquinoline-8-sulfonamide
CKI-7 is a potent and ATP-competitive casein kinase 1 (CK1) inhibitor with an IC50 of 6 μM and a Ki of 8·5 μM· CKI-7 is a selective Cdc7 kinase inhibitor· CKI-7 also inhibits SGK, ribosomal S6 kinase-1 (S6K1) and mitogen- and stress-activated protein kinase-1 (MSK1)· CKI-7 has a much weaker effect on casein kinase II and other protein kinases
ChemicalCAS120615-25-0MW285.75FormulaC11H12ClN3O2S
- CAS number
- 120615-25-0
- Molecular weight
- 285.75
- Formula
- C11H12ClN3O2S
- Solubility
- DMSO: 25 mg/mL (87·49 mM)
- InChIKey
- OGKYMFFYOWUTKV-UHFFFAOYSA-N
- Catalogue number
- GC38755
- Brand
- GLPBIO
Computed properties PubChem CID 129236 · XLogP 0.8 · TPSA 93.5 Ų · H-bond donors 2
- XLogP
- 0.8
- TPSA
- 93.5 Ų
- H-bond donors
- 2
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 18
SMILES C1=CC(=C2C=CN=CC2=C1S(=O)(=O)NCCN)Cl
Computed descriptors from PubChem (CID 129236), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il